Ruggaard & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-354
| Closed | -$372K | – | 116 |
|
|
2024
Q3 | $372K | Hold |
354
| – | – | 0.16% | 83 |
|
|
2024
Q2 | $372K | Buy |
354
+2
| +0.6% | +$2.1K | 0.17% | 79 |
|
|
2024
Q1 | $339K | Buy |
352
+10
| +3% | +$9.63K | 0.16% | 87 |
|
|
2023
Q4 | $300K | Sell |
342
-61
| -15% | -$53.6K | 0.16% | 88 |
|
|
2023
Q3 | $332K | Sell |
403
-2
| -0.5% | -$1.65K | 0.2% | 75 |
|
|
2023
Q2 | $291K | Hold |
405
| – | – | 0.17% | 85 |
|
|
2023
Q1 | $333K | Buy |
+405
| New | +$333K | 0.21% | 69 |
|